Influence of treatment of hepatocellular carcinoma before liver transplantation on postransplant tumor recurrence and survival;Influencia del tratamiento del hepatocarcinoma antes del trasplante hepático en la recurrencia tumoral y supervivencia postrasplante

Gastroenterologia y Hepatologia

Volumn 33, Issue 3, 2010, Pages 155-164

  Díaz Sánchez, Antonio ^a,b   Matilla, Ana ^a   Núñez, Oscar ^a,c   Merino, Beatriz ^a   Peligros, Isabel ^d   Rincón, Diego ^a   Salcedo, Magdalena ^a   Lo Iacono, Oreste ^a,e   Vega Catalina, María ^a   Clemente, Gerardo ^a   Bañares, Rafael ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e Aranjuez   (Spain)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Radiofrequency ablation; Transarterial chemoembolization

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RADIOFREQUENCY ABLATION; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOXORUBICIN; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; IODIZED OIL; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS;

EID: 76749135131     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2009.10.001     Document Type: Article

References (39)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Parkin D.M., Bray F., Ferlay J., and Pisan P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
3. Llovet J.M., Fuster J., Bruix J., and for the Barcelona Clinic Liver Cancer (BCLC) Group. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 30 (1999) 1434-1440
4. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
5. Disponible en: http://www.ont.es/Estadistica?id_nodo=19&accion=0&&keyword=&auditoria=F.
6. LLovet J.M., Mas X., Aponte J.J., Fuster J., Navasa M., Christensen E., et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 50 (2002) 123-128
7. Yao F.Y., Bass N.M., Nokolai B., Merriman R., Davern T.J., Kerlan R., et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy. Liver Transpl 9 (2003) 684-692
8. Chan E.Y., Larson A.M., Fix O., Yeh M., Levy A., Bakthavatsalam R., et al. Identifying risk for recurrent hepatocellular carcinoma alter liver transplantation: Implications for surveillance studies and new adjuvant therapies. Liver Transpl 14 (2008) 956-965
9. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
10. Llovet J.M., Bru C., and Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
11. Sala M., Llovet J.M., Vilana R., Bianchi L., Sole M., Ayuso C., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40 (2004) 1352-1360
12. Edmondson H., and Steiner P. Primary carcinoma of the liver: A study of 100 cases among 48.900 necropsies. Cancer 7 (1954) 462-503
13. Yao F.Y., Ferrell L., Bass N.M., Watson J.J., Bacchetti P., Venook A., et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (2001) 1394-1403
14. Veltri A., Grosso M., Martina M.C., Ciancio A., David E., Salizzoni M., et al. Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: A retrospective study. Cardiovasc Intervent Radiol 21 (1998) 393-398
15. Graziadei I.W., Sandmueller H., Waldenberger P., Koenigsrainer A., Nachbaur K., Jaschke W., et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 9 (2003) 557-563
16. Harnois D.M., Steers J., Andrews J.C., Rubin J.C., Pitot H.C., Burgart L., et al. Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 5 (1999) 192-199
17. Venook A.P., Ferrell L.D., Roberts J.P., Emond J., Frye J.W., Ring E., et al. Liver transplantation for hepatocellular carcinoma: Results with preoperative chemoembolization. Liver Transpl Surg 1 (1995) 242-248
18. Spreafico C., Marchiano A., Regalia E., Frigerio L.F., Garbagnati F., Andreola S., et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology 192 (1994) 687-690
19. Morino M., Miglietta C., Grosso M., De Giuli M., and Bismuth H. Preoperative chemoembolization for hepatocellular carcinoma. J Surg Oncol Suppl 3 (1993) 91-93
20. Ravaioli M., Grazi G.L., Ercolani G., Fiorentino M., Cescon M., Golfieri R., et al. Parcial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 78 (2004) 1780-1786
21. Fontana R.J., Hamidullah H., Nghiem H., Greenson J.K., Hussain H., Marrero J., et al. Percutaneous radiofrequency termal ablation of hepatocellular carcinoma: A safe and effective bridge to liver transplantation. Liver Transpl 8 (2002) 1165-1174
22. Mazzaferro V., Battiston C., Perrone S., Pulvirenti A., Regalia E., and Romito R. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation. Ann Surg 240 (2004) 900-909
23. Lu D.S., Yu N.C., Raman S.S., Lassman C., Tong M.J., Britten C., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41 (2005) 1130-1137
24. Porret P.M., Peterman H., Rosen M., Sonnad S., Soulen M., Markmann J.F., et al. Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 12 (2006) 665-673
25. Bharat A., Brown D.B., Crippin J.S., Gould J.E., Lowell J.A., Shenoy S., et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 203 (2006) 411-420
26. Yao F.Y., Kinkhabwala M., La Berge J.M., Bass N.M., Brown Jr. R., Kerlan R., et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 5 (2005) 795-804
27. Decaens T., Roudot-Thoraval F., Bresson-Hadni S., Meyer C., Gugenheim J., Durand F., et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 11 (2005) 767-775
28. Oldhafer K.J., Chavan A., Fruhauf N.R., Flemming P., Schlitt H.J., Kubicka S., et al. Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: Marked tumor necrosis, but no survival benefit?. J Hepatol 29 (1998) 953-959
29. Majno P.E., Adam R., Bismuto H., Castaing D., Ariche A., Krissat J., et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrosis. Ann Surg 226 (1997) 688-703
30. Mobley C., Welling T., Sonnenday C.J., Englesbe M.J., Marrero J.A., and Pelletier S.J. The effect of locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Hepatology 48 (2008) 372A
31. Stockland A.H., Walter E.M., Paz-Fumagalli R., McKinney J.M., and May G.R. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: Influence of emergent versus elective procedures in patient survival and tumor recurrente rate. Cardiovasc Intervent Radiol 30 (2007) 888-893
32. Yamashiki N., Tateishi R., Yoshida H., Shiina S., Teratani T., Sato S., et al. Ablation therapy in containig extension of hepatocellular carcinoma: A similative analysis of dropout from the waiting list for liver transplantation. Liver Transpl 11 (2005) 508-514
33. Zavaglia C., De Carlis L., Alberti A.B., Minola E., Belli L.S., Slim A.O., et al. Predictors of long therm survival alter liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 100 (2005) 2708-2716
34. Maddala Y.K., Stadheim L., Andrews J.C., Burgart L.J., Rosen C.B., Kremers W.K., et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization. Liver Transpl 10 (2004) 449-455
35. Johnson E.W., Holck P.S., Levy A.E., Yeh M.M., and Yeung R.S. The role of tumor ablation in bridging patients to liver transplantation. Arch Surg 139 (2004) 825-830
36. Pompili M., Mirante V.G., Rondinara G., Fassati L.R., Piscaglia F., Agnes S., et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and safety for tumor recurrence. Liver Transpl 11 (2005) 1117-1126
37. Brillet P.Y., Paradis V., Brancatelli G., Rangheard A.S., Consigny Y., Plessier A., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: A prospective study with histopathologic comparison. AJR 186 (2006) S296-S305
38. Livraghi T., Goldberg S.N., Lazzaroni S., Meloni F., Solbiati L., and Gazelle G.S. Small hepatocellular carcinoma: Treatment with radio-frequency ablation versus ethanol injection. Radiology 210 (1999) 655-661
39. Livraghi T., Goldberg S.N., Lazzaroni S., Meloni F., Ierace T., Solbiati L., et al. Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology 214 (2000) 761-768